The legacy of a girl who inspired a “holy grail” cancer-killing pill
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
News
Continue reading
The Oxford Scientist Schools Competition 2023: Winners Announced
Updates for The Oxford Scientist Schools Competition 2023.
New sorting algorithm is the fastest yet
Milda Folkmanaite reports on DeepMind’s new sorting algorithm, which integrates neural networks to significantly speed up data processing.
Microglia in anxiety and obsessive-compulsive disorder
Leah Fogarty reports on the new link found between the microglia and anxiety, which might offer ways of treating the disorder.
Endometriosis linked to infection with common bacteria
Sophie Beaumont reports on a newly discovered link between Fusobacterium infection and endometriosis.
Neuralink gains FDA approval for clinical trials in humans
Lola Bell reports on the FDA approval issued for Neuralink, a new technology for the brain-computer interface.
Luke Jerram in Oxford: A glass history of the pandemic
Artist Luke Jerram’s glass sculpture at the History of Science Museum showcases the pioneering Oxford vaccine research, says Elvira Miceli.
FDA approves treatment for menopausal hot flushes
Sophie Beaumont reports on a new non-hormonal drug for hot flushes, recently approved by the US Food and Drug Administration.
When size matters: New research strategies targeting cancer cells
Lola Bell reports on a new study suggesting the size of cancer cells could become a new diagnostic for directing treatment.
WHO finds that 1 in 6 people experience infertility globally
Miya McFarlane outlines the findings of a new report from the World Health Organisation suggesting an urgent need for fertility healthcare.